Sanofi Consumer Healthcare India Ltd Upgraded to Hold on Technical and Financial Improvements
2026-05-19 09:09:09Sanofi Consumer Healthcare India Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by an improved technical outlook and positive financial trends. The company’s robust quarterly results, strong management efficiency, and net-debt-free status have contributed to this reassessment, despite some concerns over valuation and long-term growth. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the recent rating change.
Read MoreSanofi Consumer Healthcare India Ltd is Rated Sell
2026-05-13 10:10:52Sanofi Consumer Healthcare India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 11 May 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 13 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read MoreSanofi Consumer Healthcare India Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-04-30 08:03:50Sanofi Consumer Healthcare India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent upgrade in price performance, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and volume-based metrics. This analysis delves into the evolving technical landscape and what it means for investors in this small-cap pharmaceutical player.
Read MoreAre Sanofi Consumer Healthcare India Ltd latest results good or bad?
2026-04-29 19:17:47Sanofi Consumer Healthcare India Ltd reported its financial results for Q4 FY26, showcasing a complex operational landscape. The company achieved a net profit of ₹67.80 crores, reflecting a year-on-year growth of 35.60% compared to ₹50.00 crores in the same quarter last year. However, this represented a modest sequential increase of 1.95% from ₹66.50 crores in the previous quarter. The net sales for the quarter were ₹229.20 crores, which indicates a year-on-year growth of 32.79% from ₹172.60 crores in Q4 FY25, although it experienced a sequential decline of 8.69% from ₹251.00 crores in Q3 FY26. This sequential decline aligns with typical seasonality trends in the consumer healthcare segment. The company's PAT margin stood at 29.58%, marking the highest quarterly margin in its recent history, which reflects strong operational leverage and effective pricing strategies. Additionally, the return on equity was ...
Read MoreWhen is the next results date for Sanofi Consumer Healthcare India Ltd?
2026-04-24 23:16:02The next results date for Sanofi Consumer Healthcare India Ltd is scheduled for April 28, 2026....
Read MoreSanofi Consumer Healthcare India Ltd Technical Momentum Shifts to Sideways Trend
2026-04-24 08:04:04Sanofi Consumer Healthcare India Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, signalling a potential stabilisation in price action. Despite mixed returns relative to the Sensex, the stock’s technical indicators such as MACD, RSI, and moving averages suggest a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector.
Read MoreSanofi Consumer Healthcare India Ltd is Rated Hold
2026-04-21 10:10:52Sanofi Consumer Healthcare India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 March 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the stock's current position as of 21 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read MoreSanofi Consumer Healthcare India Ltd Technical Momentum Shifts to Sideways Trend
2026-04-17 08:04:51Sanofi Consumer Healthcare India Ltd has recently experienced a shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. This transition is underscored by a blend of bullish and neutral signals across key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector.
Read MoreSanofi Consumer Healthcare India Ltd is Rated Hold
2026-04-10 10:10:57Sanofi Consumer Healthcare India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 March 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 10 April 2026, providing investors with the latest comprehensive analysis.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
05-Jun-2026 | Source : BSENewspaper Advertisement of 3rd Annual General Meeting is enclosed.
Reg. 34 (1) Annual Report.
04-Jun-2026 | Source : BSEPlease find enclosed Annual Report for Financial Year 2025.
Shareholder Meeting - AGM On 26Th June 2026
04-Jun-2026 | Source : BSENotice of 3rd AGM of the Company is enclosed
Corporate Actions
No Upcoming Board Meetings
Sanofi Consumer Healthcare India Ltd has declared 750% dividend, ex-date: 19 Jun 26
No Splits history available
No Bonus history available
No Rights history available